A Patient-Focused Approach to Respiratory Therapeutic Development

Expert biometrics support to improve the speed and success of your respiratory trials

Our deep data management, statistical and programming expertise ensures your respiratory trials progress smoothly and deliver meaningful patient outcomes.

Unlike other therapeutic areas that rely on breakthrough drugs, most modern clinical respiratory trials focus on improving quality of life through optimized dosing, improved compliance, and more effective treatment combinations. That’s why our trials are often centered on patient‑reported outcomes and quality‑of‑life endpoints such as FEV1 and exacerbation rates, captured through validated questionnaires like SGRQ, ACQ, and CAT.

From asthma and COPD to pulmonary fibrosis and nasal polyps, we support all phases of development with precision, agility, and insight, helping you bring better solutions to patients faster.

Our expertise

We’ve supported respiratory trials across:

All phases (I–IV), with particular experience in large-scale Phase III studies

Interim analyses and DMCs

CDISC-compliant programming and reporting

Publications and regulatory submissions

Our team understand the nuances of respiratory data such as the challenges of self-reported inhaled therapy data and the need for meticulous medication reconciliation.

How we work

We take a proactive, collaborative approach, keeping your study on track through close data monitoring, rapid issue resolution, and stakeholder alignment. Regular sponsor meetings and data reviews ensure full visibility at every stage.

Choose the solution that fits your needs:

Strategic & Technical Consulting

Specialized guidance across statistical design, data management, programming, and technology solutions

Functional Service Provider

Powering long-term success through close collaboration and bespoke integrated solutions.

Project-Based Solutions

Flexible, high-quality biometrics solutions to support clinical trials from start to finish.

Our Experts

Our respiratory team has decades of combined experience, with an average of over 12+ years working in this therapeutic area. Their expertise spans infectious diseases and respiratory viral infections, FDA interactions, protocol design, and regulatory submissions, as well as broader experience across oncology and immunology.

Discover Veramed

Your guide to the industry and our role at its cutting edge.

Driving Outcomes Through Strategic Oversight: Best Practices in Clinical Data Management

Effective data management oversight must address both technical and compliance aspects. In this blog, we explore strategic approaches to tackle clinical data management challenges.

Culture as a competitive edge: Veramed’s signature people-first approach

Veramed was reaccredited as a 3-star Best Companies workplace in November 2025. In an industry where consistency, collaboration, and retention are critical, Veramed’s people-first CRO approach offers sponsors a strategic advantage.

The Veramed Signature: Setting the new standard in biometrics

With a fresh new Veramed brand, our CEO, Troy McCall, discusses the company's mission and our ongoing commitment to the highest standards.

Detective Work in Data: A Case Study in CDISC Conversion Excellence

With outdated and incomplete datasets, Veramed helped a biotech client convert its legacy clinical trial data to CDISC-compliants formats.

Delivering Cost-Efficient, Scalable FSP Solutions for a Top 10 Global Pharma

Building on a strong partnership of over a decade, Veramed's adaptable FSP solutions enabled a global Pharma client to exceed its strategic objectives.